| CPC A61K 47/65 (2017.08) [A61K 47/6803 (2017.08); A61K 47/68037 (2023.08); A61K 47/6855 (2017.08); A61P 35/00 (2018.01); C07D 491/22 (2013.01)] | 16 Claims |
|
1. A compound of general formula (II-Ex) or a tautomer, a mesomer, a racemate, an enantiomer or a diastereoisomer thereof, or a mixture thereof, or a pharmaceutically acceptable salt thereof,
![]() wherein, X1 is saturated C, and X1 is substituted with Rn;
ring A is a four-membered saturated carbocyclyl;
p is 1, and L2 is not Rn;
L2 is —R2-L3-;
L3 is —(C(R3a)(R3b))m—, and m is selected from the group consisting of integers from 0 to 2, wherein when L3 comprises a methylene unit, 0 or 1 methylene unit of L3 may be replaced by —C(O)—;
R2 is —O—;
L1 is —(C(R5a)(R5b))n—, and n is selected from 0 or 1;
wherein when L1 comprises a methylene unit, 0 or 1 methylene unit of L1 may be replaced by —C(O)—;
wherein each R3a, each R3b, each R5a, each R5b and each Rn may each independently be hydrogen, halogen, or a C1-6 aliphatic group which may be optionally substituted with Rn;
wherein each R may independently be hydrogen or halogen.
|